跳至主要内容
临床试验/CTRI/2023/04/051266
CTRI/2023/04/051266尚未招募2 期

A single arm clinical study to evaluate the efficacy add on effect of Ajmodadi vati in the managment of Prameha with special reference to Diabetis mellitus Type2

Bhagwan Kakasaheb Muley0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with fasting blood sugar >126mg/dl upto 200mg/dl and post prandial blood sugar >200mg/dl upto 450mg/dl

排除标准

  • Diabetes mellitus type 2 Acromegaly cushings syndrome and pancreatic disorders
  • Pregnant and lactating mothers
  • Patients with known case of Diabetic nephropathy and retinopathy
  • Patients with gastrointestinal disease liver disease and tumors cardiovascular disease acute myocardial infarction DKA hyperosmolar non ketotic diabetic coma

研究者

发起方
Bhagwan Kakasaheb Muley

相似试验